Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28851 - 28875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dactinomycin	Approved Investigational	SOS1	6654	downregulated	Dactinomycin results in decreased expression of SOS1 mRNA	2p22.1	A21894
Dactinomycin	Approved Investigational	SPATA18	132671	upregulated	Dactinomycin results in increased expression of SPATA18 mRNA	4q12	A21863
Dactinomycin	Approved Investigational	STAT1	6772	upregulated	Dactinomycin results in increased expression of STAT1 mRNA	2q32.2	A21894
Dactinomycin	Approved Investigational	STMN3	50861	upregulated	Dactinomycin results in increased expression of STMN3 mRNA	20q13.33	A21863
Dactinomycin	Approved Investigational	STOM	2040	upregulated	Dactinomycin results in increased expression of STOM mRNA	9q33.2	A21863
Dactinomycin	Approved Investigational	TAP1	6890	upregulated	Dactinomycin results in increased expression of TAP1 mRNA	6p21.32	A21863
Dactinomycin	Approved Investigational	TNFRSF10B	8795	downregulated	Dactinomycin results in decreased expression of TNFRSF10B mRNA	8p21.3	A21580
Dactinomycin	Approved Investigational	TNFSF9	8744	upregulated	Dactinomycin results in increased expression of TNFSF9 mRNA	19p13.3	A21863
Dactinomycin	Approved Investigational	TP53I11	9537	downregulated	Dactinomycin results in decreased expression of TP53I11 mRNA	11p11.2	A20901
Dactinomycin	Approved Investigational	TUBA4A	7277	upregulated	Dactinomycin results in increased expression of TUBA4A mRNA	2q35	A21863
Dactinomycin	Approved Investigational	VMP1	81671	downregulated	Dactinomycin results in decreased expression of VMP1 mRNA	17q23.1	A20596
Daidzin	Experimental	FOS	2353	upregulated	daidzin results in increased expression of FOS mRNA	14q24.3	A21285
Dalcetrapib	Investigational	CYP11B1	1584	upregulated	dalcetrapib results in increased expression of CYP11B1 mRNA	8q24.3	A20668
Dalcetrapib	Investigational	CYP11B2	1585	upregulated	dalcetrapib results in increased expression of CYP11B2 mRNA	8q24.3	A20668
Dalcetrapib	Investigational	NOX4	50507	upregulated	dalcetrapib results in increased expression of NOX4 mRNA	11q14.3	A20668
Dalcetrapib	Investigational	NR3C1	2908	upregulated	dalcetrapib results in increased expression of NR3C1 mRNA	5q31.3	A20668
Dalcetrapib	Investigational	NR3C2	4306	upregulated	dalcetrapib results in increased expression of NR3C2 mRNA	4q31	A20668
Dalcetrapib	Investigational	PPARG	5468	upregulated	dalcetrapib results in increased expression of PPARG mRNA	3p25.2	A20668
Dalcetrapib	Investigational	STAR	6770	upregulated	dalcetrapib results in increased expression of STAR mRNA	8p11.23	A20668
Dantron	Approved Withdrawn	AIFM1	9131	upregulated	danthron results in increased expression of AIFM1 mRNA	Xq26.1	A21898
Dantron	Approved Withdrawn	CASP3	836	upregulated	danthron results in increased expression of CASP3 mRNA	4q35.1	A21898
Dantron	Approved Withdrawn	CASP8	841	upregulated	danthron results in increased expression of CASP8 mRNA	2q33.1	A21898
Dantron	Approved Withdrawn	CASP9	842	upregulated	danthron results in increased expression of CASP9 mRNA	1p36.21	A21898
Dantron	Approved Withdrawn	ENDOG	2021	upregulated	danthron results in increased expression of ENDOG mRNA	9q34.11	A21898
Darinaparsin	Investigational	A2M	2	upregulated	darinaparsin results in increased expression of A2M mRNA	12p13.31	A20760

Displaying entries 28851 - 28875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability